Literature DB >> 22640890

[TRP calcium channel and breast cancer: expression, role and correlation with clinical parameters].

Halima Ouadid-Ahidouch1, Isabelle Dhennin-Duthille, Mathieu Gautier, Henri Sevestre, Ahmed Ahidouch.   

Abstract

Breast cancer (BC) has the highest incidence rate in women in industrialized countries. Statistically, it is estimated that one out of 10 women will develop BC during her life. Evidence is accumulating for the role of ion channels in the development of cancer. Most studied ion channels in BC are K(+) channels, which are involved in cell proliferation, cell cycle progression and cell migration, and Na(+) channels, which correlate with invasiveness. Emerging studies demonstrated the role of Ca(2+) signaling in cancer cell proliferation, survival and migration. Recent findings demonstrated that the expression and/or activity of the transient receptor potential (TRP) channels are altered in several cancers. Among the TRP families, TRPC (canonical or classical), TRPM (melastatin) and TRPV (vanilloid) are related to malignant growth and cancer progression. Although these channels are frequently and abundantly expressed in many tumors, their specific expression, activity and roles in BC are still poorly understood. The expression of TRP channels has also been proposed as a tool for diagnosis, prognosis and/or therapeutic issues of several diseases. In cancer, TRPV6 and TRPM8 have been proposed as tumor progression markers of prostate cancer outcome and TRPC6 as a novel therapeutic target for esophageal carcinoma. Interestingly high levels of TRPC3 expression correlate with a favorable prognosis in patients with lung adenocarcinoma. Our team has recently reported the expression and role of TRPC1, TRPC6, TRPM7, TRPM8 and TRPV6 in BC cell lines and primary cultures. We have also investigated TRP expression and their clinical significance in human breast adenocarcinoma and we suggest that TRP channels are new potential BC markers. Indeed TRPC1 and TRPM8 may be considered as good prognosis markers of well-differentiated tumors, TRPM7 as a proliferative marker of poorly differentiated tumors and TRPV6 as a prognosis marker of aggressive cancers. In this review, we summarize the data reported to date regarding the changes in TRP expression associated with BC. We also discuss the importance of TRP channels in BC cells proliferation and migration and their interest as new BC markers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22640890     DOI: 10.1684/bdc.2012.1595

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  15 in total

1.  High expression of calcium channel subtypes in uterine fibroid of patients.

Authors:  Xiaoping Ke; Zhongping Cheng; Xiaoyan Qu; Hong Dai; Wenchao Zhang; Zi-Jiang Chen
Journal:  Int J Clin Exp Med       Date:  2014-05-15

2.  TRPM8 promotes aggressiveness of breast cancer cells by regulating EMT via activating AKT/GSK-3β pathway.

Authors:  Jinxin Liu; Yizhi Chen; Shuai Shuai; Dapeng Ding; Rong Li; Rongcheng Luo
Journal:  Tumour Biol       Date:  2014-06-06

3.  Down-regulation of TRPV6 Is Associated With Adverse Prognosis in Hepatocellular Carcinoma Treated With Curative Resection.

Authors:  Hyun Hee Koh; Sangjoon Choi; Cheol-Keun Park; Sang Yun Ha
Journal:  Cancer Genomics Proteomics       Date:  2022 Mar-Apr       Impact factor: 4.069

4.  Bioelectric Control of Metastasis in Solid Tumors.

Authors:  Samantha L Payne; Michael Levin; Madeleine J Oudin
Journal:  Bioelectricity       Date:  2019-09-16

5.  Identification of TRPCs genetic variants that modify risk for lung cancer based on the pathway and two-stage study.

Authors:  Zili Zhang; Jian Wang; Jianxing He; Xiansheng Zeng; Xindong Chen; Mingmei Xiong; Qipeng Zhou; Meihua Guo; Defu Li; Wenju Lu
Journal:  Meta Gene       Date:  2016-07-08

6.  Serum calcium levels, TRPM7, TRPC1, microcalcifications, and breast cancer using breast imaging reporting and data system scores.

Authors:  Shravya Mandavilli; Brij B Singh; Abe E Sahmoun
Journal:  Breast Cancer (Dove Med Press)       Date:  2012-12-28

Review 7.  A Molecular View of Pathological Microcalcification in Breast Cancer.

Authors:  Tanu Sharma; James A Radosevich; Geeta Pachori; Chandi C Mandal
Journal:  J Mammary Gland Biol Neoplasia       Date:  2016-01-15       Impact factor: 2.673

8.  Expression profiling of ion channel genes predicts clinical outcome in breast cancer.

Authors:  Jae-Hong Ko; Eun A Ko; Wanjun Gu; Inja Lim; Hyoweon Bang; Tong Zhou
Journal:  Mol Cancer       Date:  2013-09-22       Impact factor: 27.401

9.  Knockdown of TRPM8 suppresses cancer malignancy and enhances epirubicin-induced apoptosis in human osteosarcoma cells.

Authors:  Yongzhi Wang; Zhonghua Yang; Zhe Meng; Hong Cao; Guangbin Zhu; Tao Liu; Xinghuan Wang
Journal:  Int J Biol Sci       Date:  2013-12-22       Impact factor: 6.580

10.  MycN promotes TRPM7 expression and cell migration in neuroblastoma through a process that involves polyamines.

Authors:  Ingo Lange; Dana-Lynn T Koomoa
Journal:  FEBS Open Bio       Date:  2014-10-30       Impact factor: 2.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.